Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed)

The summary for the Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed): This Funding Opportunity Announcement (FOA) invites an application to continue a Connectome Coordination Facility.The competition is limited to the R24 awardee of RFA-MH-15-750.The goal of this award is to (1) maintain a central data repository for Human Connectome data; (2) provide a helpdesk service to answer questions from investigators who are trying to collect data that are compatible with the existing Human Connectome data; and (3) to serve, in a limited capacity, to check quality control and harmonize data from existing Connectome awardees.

Federal Grant Title:	Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education Environment Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-MH-20-210
Type of Funding:	Grant
CFDA Numbers:	93.113, 93.121, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.361, 93.853, 93.865, 93.866, 93.867
CFDA Descriptions:	Information not provided
Current Application Deadline:	June 24th, 2019
Original Application Deadline:	June 24th, 2019
Posted Date:	January 25th, 2019
Creation Date:	January 25th, 2019
Archive Date:	July 30th, 2019
Total Program Funding:
Maximum Federal Grant Award:	$900,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	January 25th, 2019

Applicants Eligible for this Grant: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. see the funding announcement for eligibility details
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-210.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clini...; • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic ...; • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clini...; • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed); • Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...; • Outstanding New Environmental Scientist Award (ONES); • Environmental Health Sciences Core Center Grants; • Leiomyomata Uteri: Basic Science and Translational Research
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...